Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis01:18

Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis

779
Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
779

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Nanomaterial-Based Electrochemical Biosensors Enable Sensitive Detection of Disease-Related Small-Molecule Biomarkers for Diagnostics.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Stimuli-Responsive Drug Delivery Systems for Enhanced Melanoma Immunotherapy.

Drug design, development and therapy·2025
Same author

Co-Delivery of Dacarbazine and miRNA 34a Combinations to Synergistically Improve Malignant Melanoma Treatments.

Drug design, development and therapy·2025
Same author

Cell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment.

Pharmaceutics·2024
Same author

Dendritic Cell-Derived Exosomes Driven Drug Co-Delivery Biomimetic Nanosystem for Effective Combination of Malignant Melanoma Immunotherapy and Gene Therapy.

Drug design, development and therapy·2023
Same author

Research on Vibration Amplitude of Ultra-Precision Aerostatic Motorized Spindle under the Combined Action of Rotor Unbalance and Hydrodynamic Effect.

Sensors (Basel, Switzerland)·2023
Same journal

RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n - 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. <i>Pharmaceutics</i> 2022, <i>14</i>, 1322.

Pharmaceutics·2026
Same journal

Correction: Mohite et al. Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review. <i>Pharmaceutics</i> 2025, <i>17</i>, 855.

Pharmaceutics·2026
Same journal

Metal Nanoparticle-Reinforced Hydrogels Applied in the Inhibition of Clinical Pathogens: Structural Features, Mechanisms, and Biomedical Prospects.

Pharmaceutics·2026
Same journal

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Cipepofol Across Diverse Clinical Populations.

Pharmaceutics·2026
Same journal

Artificial Intelligence in Nanopharmaceutical Development: From Predictive Design to Clinical Translation.

Pharmaceutics·2026
Same journal

Textilinin-1, a Snake Venom-Derived Kunitz-Type Protease Inhibitor, Accelerates Wound Healing Through Anti-Inflammatory, Antibacterial, and Pro-Regenerative Activities.

Pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: May 20, 2025

Formulating and Characterizing an Exosome-based Dopamine Carrier System
06:08

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Published on: April 4, 2022

3.0K

Drug Delivery Systems Based on Dendritic-Cell-Derived Exosomes.

Lihua Chen1, Jie Zhang2, Yueyan Huang2

  • 1College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.

Pharmaceutics
|March 27, 2025
PubMed
Summary
This summary is machine-generated.

Dendritic-cell-derived exosomes (DC-Exos) are promising drug delivery vehicles due to their immune-modulating properties. This review explores their characteristics, drug loading methods, and therapeutic applications in disease treatment.

Keywords:
dendritic cellsdrug delivery systemexosomesimmunotherapy

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

24.8K
Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

1.6K

Related Experiment Videos

Last Updated: May 20, 2025

Formulating and Characterizing an Exosome-based Dopamine Carrier System
06:08

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Published on: April 4, 2022

3.0K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

24.8K
Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

1.6K

Area of Science:

  • Biomedical Research
  • Nanotechnology
  • Immunology

Background:

  • Exosomes are cell-secreted nanoparticles with significant potential as drug delivery systems.
  • Dendritic-cell-derived exosomes (DC-Exos) exhibit unique surface proteins (MHC-I, MHC-II, CD80, CD86) crucial for immune response modulation.
  • These properties enable DC-Exos to facilitate antigen presentation and T-cell activation, making them attractive for therapeutic applications.

Purpose of the Study:

  • To review the characteristics of DC-Exos as drug delivery vehicles.
  • To discuss current methods and types of drug loading into DC-Exos.
  • To explore surface modifications and applications of DC-Exos in disease treatment.

Main Methods:

  • Literature review of existing research on DC-Exos.
  • Analysis of DC-Exos characteristics, drug loading techniques, and surface modification strategies.
  • Discussion of therapeutic applications in immune diseases and cancer therapy.

Main Results:

  • DC-Exos possess inherent immune-stimulatory capabilities.
  • Various drug loading strategies can be employed to load therapeutic agents into DC-Exos.
  • Surface modifications can enhance the targeting and efficacy of DC-Exos.

Conclusions:

  • DC-Exos represent a versatile and effective platform for drug delivery in immunotherapy and cancer treatment.
  • Further development of exosome-based theranostic nanoplatforms holds promise for advancing healthcare.
  • Continued research into nanotechnology for exosome engineering is essential for improved therapeutic outcomes.